What you should know:
1. The company is in discussions to execute one or more strategic agreements.
2. Medicrea said the company is pursuing opportunities around its UNiD proprietary spine software platform.
3. Medicrea said it turned down similar offers in 2019 “significantly above trading prices.”
4. Medicrea hired investment back Cowen and Co., to serve in an advisory capacity.
More articles on devices:
Dr. Hugh Bassewitz predicts more spine surgeons migrating to robotic technology
Planned $240M University of Rochester facility to provide spine, orthopedic care
Alphatec 2019 revenue hits $113M: 5 things to know
